Overview
- 35 inspections across 35 sites are on record.
- 82 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-08.
At a glance
Inspections
35
Sites
35
Observations
82
Career since
Mar 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| PPL Healthcare LLC | 8 May 2026 | Human Drugs | On file |
| Novel Laboratories, Inc. d.b.a Lupin Somerset | 17 Apr 2026 | Human Drugs | On file |
| Pharmaceutics International, Inc. | 6 Mar 2026 | Human Drugs | On file |
| Micron Inc | 19 Dec 2025 | Human Drugs | On file |
| Marlex Pharmaceuticals, Inc. | 14 Nov 2025 | Human Drugs | On file |
Sites inspected
PPL Healthcare LLCSellersville, United States1 insp.
Novel Laboratories, Inc. d.b.a Lupin SomersetSomerset, United States1 insp.
Pharmaceutics International, Inc.Cockeysville, United States1 insp.
Micron IncWilmington, United States1 insp.
Marlex Pharmaceuticals, Inc.New Castle, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Brian S Keefer6 shared
David A Oluwo3 shared
Jacob M Dyer3 shared
Daniel W Johnson2 shared
Michelle Lin1 shared
Pushpa S Jayasekara1 shared
Tanya R Syffrard1 shared
Anthony J Donato1 shared
Christopher J Brown1 shared
Kelli F Dobilas1 shared
Full investigator report
Get the verbatim findings behind Daniel T Lee's 82 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site